Her3-mutant Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2019-01-22
Clinical Trial Update: An Explorative Study of Afatinib in the Treatment of Advanced Cancer Carrying an EGFR, a HER2 or a HER3 Mutation [Phase 2]
An update on a Phase 2 exploratory trial of afatinib for advanced cancers harboring EGFR, HER2, or HER3 mutations. The trial status is curre…